A recent Cochrane review appraising the effectiveness of treatment to eliminate Hp for prevention of gastric cancer highlights evidence consistent with the hypothesis that intestinal metaplasia is a “point of no return” in the carcinogenesis pathway [48]. This evidence concerns the gene HP and gastric cancer.